EP4183412
RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME
Zusammenfassung
The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.
Anmelder
GLAXOSMITHKLINE BIOLOGICALS SA [BE]
Erfinder
SWANSON KURT [US]DORMITZER PHILIP R [US]
Externe Quellen
Klassifikation
IPC-Klassen
A61K 39/155C07K 14/135C07K 16/10
CPC-Klassen
A61K 39/12A61K 39/155A61P 11/00A61P 31/14A61P 37/04C07K 14/005C07K 16/11
AI: Life Sciences
warum
GSK RSV vaccine — A61K39/155 (vaccines). Pure biopharma.